ClinicalTrials.Veeva

Menu

HUNgarian COronaVirus Disease-19 Epidemiological Research

S

Semmelweis University

Status

Unknown

Conditions

Coronavirus Infection

Study type

Observational

Funder types

Other

Identifiers

NCT04370067
H-UNCOVER

Details and patient eligibility

About

Hungarian CoronaVirus disease-19 Epidemiological Research

Full description

The planned large-scale, cross-sectional, representative population screening can show the prevalence of COVID-19 and the degree of infection and trans-infection in Hungary after more than one month of strict restriction. In addition, it can have an impact on further actions, and we can track the impact of the decisions we make by repeating the screenings.

Enrollment

11,200 estimated patients

Sex

All

Ages

14+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Hungarian male or female patients aged 14 and over who live in private households
  • Inactivated social security number does not infer the exclusion of the study

Exclusion criteria

  • Patients under the age of 14
  • Patients living in institutional households

Trial contacts and locations

4

Loading...

Central trial contact

Annamaria Kosztin, MD,PhD; Béla Merkely, PhD,DSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems